JUL 16, 2022 2:05 PM PDT

Whole Blood Exchange May Reduce Amyloid Plaques in Alzheimer's

WRITTEN BY: Annie Lennon

Whole blood exchange reduces the formation of amyloid beta plaques in mouse models of Alzheimer's disease. The corresponding study was published in Nature

A buildup of amyloid proteins in the brain is thought to play a central role in Alzheimer's disease. Many researchers are thus working on potential treatments to target these proteins and prevent them from aggregating in the brain. However, a key complication in developing such treatments is delivering them across the blood-brain barrier. 

In the current study, researchers performed whole blood exchange treatments that partially replaced blood from mice with amyloid buildups with complete blood from healthy mice from the same genetic background. 

They found that after several blood transfusions, the development of cerebral amyloid plaques in mouse models of Alzheimer's reduced by 40%- 80%. They also reported improved spatial memory performance in aged mice and lowered rates of plaque growth over time. 

"This article provides a proof-of-concept for the utilization of technologies commonly used in medical practice, such as plasmapheresis or blood dialysis, to 'clean' blood from Alzheimer's patients, reducing the buildup of toxic substances in the brain," said senior author Claudio Soto, Ph.D., professor in the Department of Neurology with McGovern Medical School at UTHealth Houston.

"This approach has the advantage that the disease can be treated in the circulation instead of in the brain," he added. 

The researchers note that they still do not know exactly how blood exchange reduces amyloid pathology and improves memory. One theory, they noted, is that lowering amyloid beta proteins in the blood may help redistribute the peptide from the brain to the periphery. Other theories include that blood exchange may somehow prevent amyloid beta influx or inhibit the re-uptake of cleared amyloid beta. 

Whatever the underlying mechanisms, the researchers note their findings suggest that a target for Alzheimer's disease may lie in peripheral circulation as opposed to beyond the blood-brain barrier. 


Sources: Neuroscience News, Nature

About the Author
University College London
Annie Lennon is a writer whose work also appears in Medical News Today, Psych Central, Psychology Today, and other outlets. When she's not writing, she is COO of Xeurix, an HR startup that assesses jobfit from gamified workplace simulations.
You May Also Like
JUL 24, 2022
Microbiology
Host Cell Proteins That Aid Lassa Virus & A Way to Stop One of Them
JUL 24, 2022
Host Cell Proteins That Aid Lassa Virus & A Way to Stop One of Them
Lassa virus infections are asymptomatic in about 80 percent of people. But the virus also causes Lassa fever (LF), which ...
AUG 18, 2022
Cannabis Sciences
Metered-Dose Inhalers Offer Effective Dosing for Medical Cannabis Patients
AUG 18, 2022
Metered-Dose Inhalers Offer Effective Dosing for Medical Cannabis Patients
A recent study published in Canadian Journal of Health Technologies examined the effectiveness of using metered-dose inh ...
AUG 21, 2022
Drug Discovery & Development
Eczema Drug Helps Increase Covid-19 Survival Rates, Clinical Study Suggests
AUG 21, 2022
Eczema Drug Helps Increase Covid-19 Survival Rates, Clinical Study Suggests
In a recent study published in Open Forum Infectious Diseases, a clinical study led by the University of Virginia (UVA) ...
SEP 04, 2022
Drug Discovery & Development
Deep Brain Stimulation Shows Promise for Binge-Eating Disorder
SEP 04, 2022
Deep Brain Stimulation Shows Promise for Binge-Eating Disorder
Deep brain stimulation (DBS) may help control symptoms of binge-eating disorder and induce weight loss. The correspondin ...
SEP 26, 2022
Immunology
A Rheumatoid Arthritis-Promoting Molecule is Identified
SEP 26, 2022
A Rheumatoid Arthritis-Promoting Molecule is Identified
Researchers have found that a protein called sulfatase-2 may play a significant role in the tissue damage caused by rheu ...
SEP 22, 2022
Drug Discovery & Development
A new drug to treat the positive and negative symptoms of schizophrenia
SEP 22, 2022
A new drug to treat the positive and negative symptoms of schizophrenia
Schizophrenia is a severe psychiatric disorder that can affect an individual’s ability to properly inter ...
Loading Comments...